Skip to main content

Advertisement

Log in

Albuminuria and left ventricular mass index are associated with left ventricular diastolic dysfunction in type 2 diabetes mellitus patients

  • Original Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Background

Diabetes mellitus (DM) is associated with a substantially increased risk of developing heart failure. To verify the risk factors of preclinical left ventricular diastolic dysfunction (LVDD) in type 2 diabetic patients, we assessed the LVDD by tissue Doppler echocardiography and its relationship with various parameters in asymptomatic patients with type 2 DM.

Methods

We studied 100 asymptomatic patients with type 2 DM [age 61.6 ± 9.7 years, body mass index (BMI) 25.5 ± 4.8 kg/m2]. All patients underwent clinical evaluation, retinopathy, and laboratory assessment for BMI, fasting plasma glucose, C-peptide, lipids, Hemoglobin A1c (HbA1c), and urine albumin to creatinine ratio. Echocardiography including tissue Doppler imaging were performed to assess LVDD, which was defined with E/A < 0.75; or with 0.75 ≤ E/A and E/e’ ≥ 10. Normal diastolic function was defined with 0.75 ≤ E/A < 1.5 and E/e’ < 10. Patients with LV ejection fraction (LVEF) <50 % were excluded.

Results

Sixty-five patients were classified as having LVDD and 35 as having normal diastolic function. The logistic analysis revealed that age [odds ratio (OR) 1.14, 95 % confidence interval (CI) 1.06–1.22, P = 0.001), women (OR 7.63, 95 % CI 2.18–26.7, P = 0.002), left ventricular mass index (LVMI) (OR 1.04, 95 % CI 1.01–1.08, P = 0.004), and albuminuria (OR 7.95 95 % CI 1.74–21.6, P = 0.005) were associated with LVDD.

Conclusion

This study reveals a high incidence of LVDD in asymptomatic type 2 DM patients and, this finding was correlated with age, sex, LVMI and albuminuria. Screening for albuminuria and echocardiography may be useful for identifying individuals with a high cardiovascular risk and possible LVDD in type 2 DM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27:699–703.

    Article  PubMed  Google Scholar 

  2. Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlöf B, Ibsen H, et al. Hospitalizations for new heart failure among patients with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol. 2005;96:1530–6.

    Article  PubMed  Google Scholar 

  3. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202.

    Article  PubMed  Google Scholar 

  4. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, Krumholz HM. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol. 2003;41:217–23.

    Article  PubMed  Google Scholar 

  5. Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, Scherer M, et al. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia. 2010;53:1331–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2:358–67.

    Article  CAS  PubMed  Google Scholar 

  7. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.

    Article  CAS  PubMed  Google Scholar 

  8. Park JH, Marwick TH. Use and Limitations of E/e’ to assess left ventricular filling pressure by echocardiography. J Cardiovasc Ultrasound. 2011;19:169–73.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Srivastava PM, Calafiore P, Macisaac RJ, Patel SK, Thomas MC, Jerums G, Burrell LM. Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes. Clin Sci (Lond). 2008;114:313–20.

    Article  Google Scholar 

  10. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24:5–10.

    Article  CAS  PubMed  Google Scholar 

  11. Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004;93:870–5.

    Article  PubMed  Google Scholar 

  12. Russo C, Zhezhen J, Homma S, Rundek T, Elkind MSV, Sacco RL, et al. Race/Ethnic disparities in left ventricular diastolic function in a tri-ethnic community cohort. Am Heart J. 2010;160:152–8.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Okura H, Takada Y, Yamabe A, Kubo T, Asawa K, Ozaki T, et al. Age- and gender-specific changes in the left ventricular relaxation: a Doppler echocardiographic study in healthy individuals. Circ Cardiovascular Imaging. 2009;2:41–6.

    Article  Google Scholar 

  14. Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the strong heart study. J Am Coll Cardiol. 2003;4(41):2022–8.

    Article  Google Scholar 

  15. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML. Zelmanovitz T Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–76.

    Article  PubMed  Google Scholar 

  16. Cosson E, Pham I, Valensi P, Pariès J, Attali JR, Nitenberg A. Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care. 2006;29:107–12.

    Article  PubMed  Google Scholar 

  17. Freedman BI, Langefeld CD, Lohman KK, Bowden DW, Carr JJ, Rich SS, et al. Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. J Am Soc Nephrol. 2005;16:2156–61.

    Article  CAS  PubMed  Google Scholar 

  18. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319–23.

    Article  CAS  PubMed  Google Scholar 

  19. Dobre D, Nimade S, de Zeeuw D. Albuminuria in heart failure: what do we really know? Curr Opin Cardiol. 2009;24:148–54.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tatsuo Yanagawa.

About this article

Cite this article

Akiyama, T., Eto, Y., Matsuda, H. et al. Albuminuria and left ventricular mass index are associated with left ventricular diastolic dysfunction in type 2 diabetes mellitus patients. Diabetol Int 5, 129–133 (2014). https://doi.org/10.1007/s13340-013-0146-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-013-0146-7

Keywords

Navigation